Antibiotic resistance is a bacterial defense mechanism against antibiotics. It can rapidly spread from one bacterium to another. This makes antibiotics increasingly ineffective.
Detailed description
The level of resistances against antibiotics is rising. This is a great challenge for physicians and scientists. Scientists within the DZIF research field “Healthcare-associated and Antibiotic-resistant bacterial Infections” aim to develop new strategies against the development and spread of resistance.
Members of Parliament (MPs) from the CDU, FDP, SPD and Die Linke parties have joined forces in a parliamentary group to focus more on combating antimicrobial resistance in the future.
Prof. Dr Christoph Ernst from the Institute of Medical Microbiology, Immunology and Hygiene at the University Hospital of Cologne and the Faculty of Medicine has been selected for the Boehringer
According to estimates, 4.95 million deaths worldwide in 2019 were directly or indirectly attributable to infections with resistant bacteria. The rising number of resistant bacterial pathogens, also
Please use image only in connection with this press release.
Most antibiotics used in human medicine originate from natural products derived from bacteria and other microbes. Novel microorganisms are therefore a promising source of new active compounds—also for
Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers at the University Hospital Bonn (UKB), the University of Bonn and
Please use this image only in connection with this press release.
Antibiotic resistance is one of the challenges facing mankind in the 21st century. This includes antibiotic-resistant tuberculosis. Just in time for World Tuberculosis Day on 24 March 2024, the
While tuberculosis (TB) has become relatively rare in Germany and other industrialised nations, around ten million people contract the bacterial infection every year, especially in resource-poorer
New active substances for the treatment of resistant bacteria are needed more urgently than ever – yet only few candidates make the leap from research to clinical application. To facilitate precisely
Tuberculosis and malaria are among the deadliest infectious diseases worldwide and are increasingly spreading, not least due to climate change. In both cases, antimicrobial resistance renders
